Gemcitabine and docetaxel compared to radiation or other chemotherapy regimens as adjuvant treatment for stage I-IV uterine leiomyosarcoma

Roque, Dario

370
Gemcitabine and docetaxel compared to radiation or other chemotherapy regimens as adjuvant treatment for stage I-IV uterine leiomyosarcoma

Sunday, March 29, 2015: 7:00 AM

Salon C-D (Hilton Chicago)

D. R. Roque¹, K. Taylor², M. Palisoul³, W. Z. Wysham¹, B. Milam¹, K. M. Robison², P. A. Gehrig¹, C. Raker² and K. H. Kim¹
¹University of North Carolina at Chapel Hill, Chapel Hill, NC, ²Women & Infants Hospital, Brown University, Providence, RI, ³Brown University OBGYN, Providence, RI

2015 Annual Meeting on Women's Cancer®

March 26 - 31, 2015

Navigation

370
Gemcitabine and docetaxel compared to radiation or other chemotherapy regimens as adjuvant treatment for stage I-IV uterine leiomyosarcoma

370 Gemcitabine and docetaxel compared to radiation or other chemotherapy regimens as adjuvant treatment for stage I-IV uterine leiomyosarcoma

370
Gemcitabine and docetaxel compared to radiation or other chemotherapy regimens as adjuvant treatment for stage I-IV uterine leiomyosarcoma